An Important Measure of Therapeutic Response in MS
March 25th, 2011 by kathibbetson
A study published in the Lancet Neurology this month assessed the efficacy and safety of cladribine for RRMS
Prevention of EAE by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.
March 9th, 2011 by kathibbetson
This study examined the long term effects of the opioid growth factor (OGF, [Met(5)]-enkephalin) and a low dose of the opioid blocker naltrexone (LDN) on induced EAE
Action, Rather than Coping Techniques, Helped MS Patients During Second Lebanon War
March 1st, 2011 by kathibbetson
Patients who focused their coping on emotional wellbeing when a more direct approach was necessary, suffered more flare-ups of the disease than patients who identified the challenges that the falling missiles were presenting, and regarded the situation as an opportunity for planning and direct action,”
Tags: emotional support, emotional wellbeing, exacerbation, flare ups, ms symptoms, multiple sclerosis, relaxation techniques, stress factorPosted in
Emotional changes after a diagnosis of Multiple Sclerosis
February 27th, 2011 by kathibbetson
MS changes us. It causes us to rethink our plans, goals, dreams and aspirations: some changes may be relatively small but some are very significant, and affect several areas of our life.
Tags: chronic illness, grieving process, lifestyle, management strategies, ms diagnosis, multiple sclerosisPosted in
Cognition in MS
February 22nd, 2011 by kathibbetson
For many, the emotional and cognitive effects of Multiple Sclerosis represent its greatest challenges. Whether a person with MS will experience these problems cannot be predicted from age, level of physical disability, duration of MS, type of MS, or intelligence tests. U
Tags: cognitive decline, cognitive dysfunction, emotional reactions, MS-related, multiple sclerosisPosted in
Pseudobulbar affect – affects 10% of people with MS
February 17th, 2011 by kathibbetson
Pseudobulbar affect (PBA) is a neurologic condition that causes sudden, frequent, and involuntary episodes of crying or laughing.
Tags: involuntary emotional expression disorder, ms symptom, ms symptoms, multiple sclerosis, pba, TreatmentsPosted in
Could Early Symptoms of MS Be Stratified to Give Better Targeted Multiple Sclerosis Treatments?
February 1st, 2011 by kathibbetson
To date MS has been unpredictable right from disease onset but , knowing the disease course is of crucial importance in guiding treatment.
Tags: disease onset, multiple sclerosis, progressive disease, Treatments, variable diseasePosted in
Improving Walking with RAS
January 28th, 2011 by kathibbetson
Not many treatments have been successful in improving gait dysfunction in patients with multiple sclerosis, but now Rhythmic auditory stimulation (RAS) has demonstrated positive results
Survey Highlights Gap Between Patient and Healthcare Professional Perceptions of Mobility Loss due to Multiple Sclerosis .
January 28th, 2011 by kathibbetson
Nearly one in two (45%) of people surveyed reported to have experienced mobility issues within the first month following diagnosis of multiple sclerosis
Tags: biogen idec, mobility impairment, mobility issues, mobility problems, multiple sclerosisPosted in
Bladder Problems in MS
January 28th, 2011 by kathibbetson
Bladder problems associated with MS can be just as unpredictable as the course of the disease itself. While statistics can help in better understanding things it remains true for any MS symptom that each person can have a different experience.
